Stocks priced between $10 and $50 often strike a balance between affordability and stability, as they tend to be more established than penny stocks. However, as highlighted in a recent Yahoo Finance article, not all stocks in this range are worth investing in, as some may have shaky fundamentals.

Read also: US Stocks Gain Amid Fed Nomination and Tariff Developments

According to data from the IndexBox platform, the average forward price-to-sales ratio for mid-cap stocks in this price range is around 3.5x, making some of the mentioned stocks appear overvalued.

C3.ai (AI): $16.45 per share

Founded in 2009, C3.ai provides AI software solutions for enterprises. However, its forward price-to-sales ratio of 5x raises concerns about its valuation compared to industry benchmarks.

Levi Strauss (LEVI): $20.34 per share

The iconic denim brand trades at a forward P/E of 15.9x, which may not justify its growth prospects in a competitive apparel market.

Acadia Healthcare (ACHC): $19.50 per share

Acadia Healthcare operates mental health facilities but trades at a forward P/E of 6.9x, signaling potential risks in its business model. Meanwhile, investors looking for stronger opportunities may consider high-momentum stocks, such as those highlighted by StockStory, which have delivered a 183% return over the past five years.

Source: IndexBox Market Intelligence Platform